XML 29 R38.htm IDEA: XBRL DOCUMENT v2.3.0.15
SHARE BASED COMPENSATION (DETAILS) (USD $)
1 Months Ended3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Share Based Compensation Expense $ 4,438,000$ 7,946,000$ 20,445,000$ 13,003,000 
Share Based Compensation Employee Stock Purchase Plan Activity Abstract      
Stock Options Outstanding Weighted Average Exercise Price Beginning of Period   $ 30.01  
Stock Options Granted Weighted Average Exercise Price$ 34.30$ 34.30 $ 34.30  
Stock Options Exercised Weighted Average Exercise Price$ 27.69$ 27.69 $ 27.69  
Stock Options Cancelled Weighted Average Exercise Price$ 36.82$ 36.82 $ 36.82  
Stock Options Outstanding Weighted Average Exercise Price End of Period$ 31.31$ 31.31 $ 31.31  
Stock Options Outstanding Number Beginning Balance   6,491,353  
Stock Options Granted Shares   79,933  
Stock Options Exercised Shares   (2,385,326)  
Stock Options Cancelled Shares   (80,705)  
Stock Options Outstanding Number Ending Balance4,105,2554,105,255 4,105,255  
Stock Options Outstanding Remaining Contractual Term2.72.7 2.7  
Stock Options Outstanding Aggregate Intrinsic Value24,374,27224,374,272 24,374,272  
Employee Stock Option [Member]
      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Plan Description   Stock option awards are granted at the fair market value on the date of grant. The option awards vest over a period determined at the time the options are granted, ranging from one to five years, and generally have a maximum term of ten years. Certain options provide for accelerated vesting if there is a change in control (as defined in the plans). When options are exercised, new shares of the Company’s Class A common stock are issued.   
Compensation Cost Not Yet Recognized1,200,0001,200,000 1,200,000  
Compensation Cost Recognition Period   2.5  
Share Based Compensation Expense 187,000307,000670,0001,145,000 
Share Based Compensation Employee Stock Purchase Plan Activity Abstract      
Total Intrinsic Value Of Options Excercised   20,534,415  
Options Excercisable Shares3,951,4433,951,443 3,951,443  
Options Excercisable Weighted Average Exercise Price$ 31.51$ 31.51 $ 31.51  
Options Exercisable Weighted Average Remaining Contractual Term   2.5  
Options Excercisable Aggregate Intrinsic Value22,784,75822,784,758 22,784,758  
Options Outstanding Vested And Expected To Vest Shares3,843,4093,843,409 3,843,409  
Options Outstanding Vested And Expected To Vest Weighted Average Exercise Price$ 31.54$ 31.54 $ 31.54  
Options Outstanding Vested And expected To Vest Aggregate Intrinsic Value21,951,97321,951,973 21,951,973  
Options Outstanding Vested And Expected To Vest Weighted Average Remaining Contractual Term   2.7  
Options Exercisable Vested And Expected To Vest Shares3,730,2813,730,281 3,730,281  
Options Exercisable Vested And Expected To Vest Weighted Average Exercise Price$ 31.64$ 31.64 $ 31.64  
Options Exercisable Vested And Expected To Vest Weighted Average Remaining Contractual Term   2.5  
Options Exercisable Vested And Expected To Vest Aggregate Intrinsic Value21,021,47221,021,472 21,021,472  
Share Based Payment Award Fair Value Assumptions And Methodology Abstract      
Fair Value Assumptions Expected Volatility Rate   0.33%0.33% 
Fair Value Assumptions Expected Life   7.07.0 
Fair Value Assumptions Risk Free Interest Rate Minimum   2.47%2.82% 
Fair Value Assumptions Risk Free Interest Rate Maximum   2.81%3.04% 
Fair Value Assumptions Risk Expected Dividend Yield Minimum   0.77%1.02% 
Fair Value Assumptions Risk Expected Dividend Yield Maximum   0.88%1.06% 
Grant Date Fair Value Of Options   $ 12.25$ 8.28 
Restricted Stock Units RSU [Member]
      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Compensation Cost Not Yet Recognized34,800,00034,800,000 34,800,000  
Compensation Cost Recognition Period   3.2  
Share Based Compensation Expense 2,794,0002,401,0008,593,0005,577,000 
Share Based Compensation Equity Instruments Other Than Options Plan Activity Abstract      
Restricted Stock Nonvested Number Beginning Balance   1,794,445  
Restricted Stock Granted Shares   758,457  
Units Vested   (485,030)  
Forfeited Units   (29,619)  
Restricted Stock Nonvested Number Ending Balance2,038,2532,038,253 2,038,253  
Restricted Stock Nonvested Weighted Average Grant Date Fair Value Beginning of Period   $ 17.94  
Restricted Stock Granted Weighted Average Grant Date Fair Value   $ 31.48  
Awards Vested Weighted Average Grant Date Fair Value   $ 19.19  
Units Cancelled Weighted Average Grant Date Fair Value$ 24.00$ 24.00 $ 24.00  
Restricted Stock Nonvested Weighted Average Grant Date Fair Value End of Period$ 22.59$ 22.59 $ 22.59  
Fair Value Of Awards Vested   9,300,0007,800,000 
Stock Appreciation Rights SARS [Member]
      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Compensation Cost Not Yet Recognized31,200,00031,200,000 31,200,000  
Compensation Cost Recognition Period   3.0  
Share Based Compensation Expense 1,457,0005,238,00011,182,0006,281,000 
Share Based Payment Award Fair Value Assumptions And Methodology Abstract      
Fair Value Assumptions Expected Volatility Rate0.33%  0.32%  
Fair Value Assumptions Expected Volatility Rate Minimum0.96%   0.32% 
Fair Value Assumptions Expected Volatility Rate Maximum1.43%   0.33% 
Fair Value Assumptions Expected Life   7.07.0 
Fair Value Assumptions Expected Life Minimum4.4     
Fair Value Assumptions Expected Life Maximum6.5     
Fair Value Assumptions Risk Free Interest Rate   3.12%  
Fair Value Assumptions Risk Free Interest Rate Minimum    2.06% 
Fair Value Assumptions Risk Free Interest Rate Maximum    3.07% 
Fair Value Assumptions Risk Expected Dividend Yield0.88%  0.87%  
Fair Value Assumptions Risk Expected Dividend Yield Minimum    0.89% 
Fair Value Assumptions Risk Expected Dividend Yield Maximum    1.06% 
Share Based Compensation Equity Instruments Other Than Options Plan Activity Abstract      
Grant Date Fair Value of Stock Appreciation Rights   $ 9.90$ 8.16 
Remeasurement Date Fair Value Of Stock Appreciation Rights$ 20.66     
Share Based Compensation Stock Appreciation Rights Plan Activity Abstract      
Stock Appreciation Rights Outstanding Weighted Average Exercise Price Beginning of Period     $ 16.99
Stock Appreciation Rights Granted Weighted Average Exercise Price$ 27.56$ 27.56 $ 27.56  
Stock Appreciation Rights Exercised Weighted Average Exercise Price$ 15.54$ 15.54 $ 15.54  
Stock Appreciation Rights Cancelled Weighted Average Exercise Price$ 16.21$ 16.21 $ 16.21  
Stock Appreciation Rights Outstanding Weighted Average Exercise Price End of Period$ 17.46$ 17.46 $ 17.46  
Stock Appreciation Rights Outstanding Number Beginning Balance     3,030,142
Stock Appreciation Rights Granted Number64,13564,135 64,135  
Stock Appreciation Rights Exercised Number(279,852)(279,852) (279,852)  
Stock Appreciation Rights Cancelled Number(191,284)(191,284) (191,284)  
Stock Appreciation Rights Outstanding Number Ending Balance2,623,1412,623,141 2,623,141  
Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term   5.0  
Stock Appreciation Rights Outstanding Aggregate Intrinsic Value49,884,86449,884,864 49,884,864  
Total Intrinsic Value Of Stock Appreciation Rights Excercised   5,701,172  
Stock Appreciation Rights Exercisable Number88,26888,268 88,268  
Stock Appreciation Rights Exercisable Weighted Average Exercise Price$ 17.35$ 17.35 $ 17.35  
Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term   5.0  
Stock Appreciation Rights Exercisable Aggregate Intrinsic Value$ 1,688,693$ 1,688,693 $ 1,688,693